Skip to Main Content

Author Details

John W M Martens
Erasmus Medical Center (MC) Cancer Institute
1989
350
72
PMIDPaper TitleJournal TitlePublished Year
37985357The effect of (neo)adjuvant chemotherapy on long-term survival outcomes in patients with invasive lobular breast cancer treated with endocrine therapy: A retrospective cohort study.Cancer2024
36196486Detection of circulating tumour DNA after neoadjuvant chemoradiotherapy in patients with locally advanced oesophageal cancer.J Pathol2023
37760576Liquid Biopsies for Colorectal Cancer and Advanced Adenoma Screening and Surveillance: What to Measure?Cancers (Basel)2023
38073130Flow-based immunomagnetic enrichment of circulating tumor cells from diagnostic leukapheresis product.Mol Oncol2023
38061007Liquid Biopsies for Early Response Evaluation of Radium-223 in Metastatic Prostate Cancer.JCO Precis Oncol2023
37479706Obesity-associated changes in molecular biology of primary breast cancer.Nat Commun2023
37947598Circulating Tumour DNA as Biomarker for Colorectal Liver Metastases: A Systematic Review and Meta-Analysis.Cells2023
37686693Genomic Alterations Associated with Estrogen Receptor Pathway Activity in Metastatic Breast Cancer Have a Differential Impact on Downstream ER Signaling.Cancers (Basel)2023
37968696Integrative whole-genome and transcriptome analysis of HER2-amplified metastatic breast cancer.Breast Cancer Res2023
37461156Improved enrichment of circulating tumor cells from diagnostic leukapheresis product.Cytometry A2023
37425956Identification of commensal gut microbiota signatures as predictors of clinical severity and disease progression in multiple sclerosis.medRxiv2023
37161532Breast cancer genomes from CHEK2 c.1100delC mutation carriers lack somatic TP53 mutations and display a unique structural variant size distribution profile.Breast Cancer Res2023
37190094Aberrant APOBEC3B Expression in Breast Cancer Is Linked to Proliferation and Cell Cycle Phase.Cells2023
37452019Tumor-agnostic ctDNA levels by mFAST-SeqS in first-line HR-positive, HER2 negative metastatic breast cancer patients as a biomarker for survival.NPJ Breast Cancer2023
36983083A Compendium of AR Splice Variants in Metastatic Castration-Resistant Prostate Cancer.Int J Mol Sci2023
37178439mFast-SeqS-based aneuploidy score in circulating cell-free DNA is a prognostic biomarker in prostate cancer.Mol Oncol2023
37369746Machine learning-based somatic variant calling in cell-free DNA of metastatic breast cancer patients using large NGS panels.Sci Rep2023
37226020Plasma ESR1 mutations and outcome to first-line paclitaxel and bevacizumab in patients with advanced ER-positive/HER2-negative breast cancer.Breast Cancer Res Treat2023
36478188Clinical Implications of APOBEC3-Mediated Mutagenesis in Breast Cancer.Clin Cancer Res2023
36814469Cost-Effectiveness of Abemaciclib in Early Breast Cancer Patients: One Size Fits All or Tailoring to Patients' Needs?Breast Cancer (Dove Med Press)2023
36621142Identifying somatic changes in drug transporters using whole genome and transcriptome sequencing data of advanced tumors.Biomed Pharmacother2023
36691073GRHL2-controlled gene expression networks in luminal breast cancer.Cell Commun Signal2023
36900167Methylated Cell-Free DNA Sequencing (MeD-seq) of LpnPI Digested Fragments to Identify Early Progression in Metastatic Renal Cell Carcinoma Patients on Watchful Waiting.Cancers (Basel)2023
36793616Circulating tumour DNA as biomarker for rectal cancer: A systematic review and meta-analyses.Front Oncol2023
36755288Tamoxifen induces radioresistance through NRF2-mediated metabolic reprogramming in breast cancer.Cancer Metab2023
35050709Apolipoprotein B mRNA-Editing Catalytic Polypeptide-Like-Induced Protein Changes in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Throughout Disease Progression.JCO Precis Oncol2022
35669415Liquid Biopsy Based Circulating Biomarkers in Metastatic Prostate Cancer.Front Oncol2022
35366566Validity and utility of HER2/ERBB2 copy number variation assessed in liquid biopsies from breast cancer patients: A systematic review.Cancer Treat Rev2022
35662281Functional RECAP (REpair CAPacity) assay identifies homologous recombination deficiency undetected by DNA-based BRCAness tests.Oncogene2022
35628441<i>ESR1</i> Methylation Measured in Cell-Free DNA to Evaluate Endocrine Resistance in Metastatic Breast Cancer Patients.Int J Mol Sci2022
35563471Lost by Transcription: Fork Failures, Elevated Expression, and Clinical Consequences Related to Deletions in Metastatic Colorectal Cancer.Int J Mol Sci2022
36477895Cis-regulatory mutations associate with transcriptional and post-transcriptional deregulation of gene regulatory programs in cancers.Nucleic Acids Res2022
36041543A kinase inhibitor screen reveals MEK1/2 as a novel therapeutic target to antagonize IGF1R-mediated antiestrogen resistance in ERα-positive luminal breast cancer.Biochem Pharmacol2022
36139564Characterizing Circulating Tumor Cells and Tumor-Derived Extracellular Vesicles in Metastatic Castration-Naive and Castration-Resistant Prostate Cancer Patients.Cancers (Basel)2022
35902644HER2-low breast cancer shows a lower immune response compared to HER2-negative cases.Sci Rep2022
35927254Molecular characterization of colorectal cancer related peritoneal metastatic disease.Nat Commun2022
36323051CABA-V7: a prospective biomarker selected trial of cabazitaxel treatment in AR-V7 positive prostate cancer patients.Eur J Cancer2022
35159019Identifying Transcripts with Tandem Duplications from RNA-Sequencing Data to Predict BRCA1-Type Primary Breast Cancer.Cancers (Basel)2022
35248823Circulating tumour cells to drive the use of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer.ESMO Open2022
35151276The prognostic and predictive value of ESR1 fusion gene transcripts in primary breast cancer.BMC Cancer2022
35181986Genome-wide aneuploidy detected by mFast-SeqS in circulating cell-free DNA is associated with poor response to pembrolizumab in patients with advanced urothelial cancer.Mol Oncol2022
34878805Prognostic Value of Circulating Tumor Cell Characteristics May Be Biased by Their Quantity.J Clin Oncol2022
34964258A pipeline for copy number profiling of single circulating tumour cells to assess intrapatient tumour heterogeneity.Mol Oncol2022
32949099Defining the dimensions of circulating tumor cells in a large series of breast, prostate, colon, and bladder cancer patients.Mol Oncol2021
33790333Differential reprogramming of breast cancer subtypes in 3D cultures and implications for sensitivity to targeted therapy.Sci Rep2021
33514525Detection of Aneuploidy in Cerebrospinal Fluid from Patients with Breast Cancer Can Improve Diagnosis of Leptomeningeal Metastases.Clin Cancer Res2021
33761899Detection of tumor-derived extracellular vesicles in plasma from patients with solid cancer.BMC Cancer2021
33648524Splicing factors control triple-negative breast cancer cell mitosis through SUN2 interaction and sororin intron retention.J Exp Clin Cancer Res2021
33920880Circular RNA in Chemonaive Lymph Node Negative Colon Cancer Patients.Cancers (Basel)2021
33920135A Systematic Review of the Use of Circulating Cell-Free DNA Dynamics to Monitor Response to Treatment in Metastatic Breast Cancer Patients.Cancers (Basel)2021
  • 1 - 50 of 350

Recommended Authors

Guanglong Jiang
Indiana University School of Medicine
Career Start Year 2011
Number of shared co-authors 0
Hans Kristian Moen Vollan
F Hoffmann-La Roche Ltd
Career Start Year 2010
Number of shared co-authors 20
Charlotte K Y Ng
University of Bern
Career Start Year 2009
Number of shared co-authors 26
Gabriele Zoppoli
University of Genoa and Ospedale Policlinico San Martino
Career Start Year 2008
Number of shared co-authors 25
Salvatore Piscuoglio
University of Basel
Career Start Year 2008
Number of shared co-authors 11
Nicola Waddell
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 61
Rut Klinger
UCD Conway Institute, University College Dublin
Career Start Year 2006
Number of shared co-authors 5
Christina Curtis
Stanford University School of Medicine
Career Start Year 2004
Number of shared co-authors 18
Katherine A Hoadley
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Career Start Year 2004
Number of shared co-authors 22
Obi L Griffith
Washington University
Career Start Year 2003
Number of shared co-authors 10
Leslie Cope
Johns Hopkins University School of Medicine
Career Start Year 2003
Number of shared co-authors 5
Siddhartha Deb
Olivia Newton-John Cancer Research Institute
Career Start Year 2002
Number of shared co-authors 2
Nicola Fusco
IEO European Institute of Oncology IRCCS
Career Start Year 2002
Number of shared co-authors 7
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 19
Joshua Chuck Harrell
Virginia Commonwealth University
Career Start Year 2002
Number of shared co-authors 1
Michael Slifker
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 0
Syed Haider
Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 50
Darran P O'Connor
UCD Conway Institute, University College Dublin
Career Start Year 2001
Number of shared co-authors 11
Richard B Schwab
Department of Medicine and Moores Cancer Center, University of California San Diego
Career Start Year 2000
Number of shared co-authors 4
Loris De Cecco
Fondazione IRCCS Istituto Nazionale dei Tumori
Career Start Year 2000
Number of shared co-authors 7
Tobias Sj??blom
Uppsala University
Career Start Year 1999
Number of shared co-authors 0
Dirce Maria Carraro
AC Camargo Cancer Center
Career Start Year 1998
Number of shared co-authors 8
Paul T Spellman
Oregon Health & Science University Hospital.
Career Start Year 1998
Number of shared co-authors 71
Jan Budczies
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1996
Number of shared co-authors 5
James D Brenton
CRUK Cambridge Institute, University of Cambridge
Career Start Year 1995
Number of shared co-authors 131
Susan J Done
University Health Network
Career Start Year 1994
Number of shared co-authors 7
Adam B Olshen
12224University of California san francisco
Career Start Year 1993
Number of shared co-authors 7
Kornelia Polyak
Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School
Career Start Year 1991
Number of shared co-authors 28
Ben Ho Park
Vanderbilt University Medical Center
Career Start Year 1990
Number of shared co-authors 12
Olli Kallioniemi
Karolinska Institute
Career Start Year 1984
Number of shared co-authors 38

Collaborators

Stefan Sleijfer
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Co-authored papers 78
Carolien H M van Deurzen
Erasmus MC Cancer Institute
Co-authored papers 52
Caroline Seynaeve
Erasmus Medical Center
Co-authored papers 34
Douglas F Easton
University of Cambridge
Co-authored papers 34
Fergus J Couch
Mayo Clinic
Co-authored papers 31
Jenny Chang-Claude
German Cancer Research Center (DKFZ)
Co-authored papers 30
Paul D P Pharoah
Center for Cancer Genetic Epidemiology, University of Cambridge
Co-authored papers 30
Per Hall
Co-authored papers 29
Alison M Dunning
Co-authored papers 29
Paul N Span
Radboud University Medical Center
Co-authored papers 29
Peter A Fasching
Otto-Friedrich-University Bamberg
Co-authored papers 28
Roger L Milne
Co-authored papers 28
Montserrat Garcia-Closas
National Cancer Institute
Co-authored papers 28
Irene L Andrulis
University of Toronto
Co-authored papers 28
Graham G Giles
Co-authored papers 28
Georgia Chenevix-Trench
QIMR Berghofer Medical Research Institute
Co-authored papers 27
Javier Ben??tez
Instituto de Salud Carlos III
Co-authored papers 26
Jonine D Figueroa
The Usher Institute, The University of Edinburgh
Co-authored papers 26
Christopher A Haiman
University of Southern California
Co-authored papers 25
Diether Lambrechts
Co-authored papers 25
Loic Le Marchand
Co-authored papers 25
Janet E Olson
Mayo Clinic
Co-authored papers 24
Paolo Radice
Ospedale Circolo e Fondazione Macchi
Co-authored papers 24
Vessela N Kristensen
Faculty of Clinical Medicine, University of Oslo
Co-authored papers 24
Hoda Anton-Culver
University of California irvine
Co-authored papers 23
Jan Lubinski
Pomeranian Medical University
Co-authored papers 23
Martijn P Lolkema
Erasmus MC Cancer Institute
Co-authored papers 23
Børge G Nordestgaard
Co-authored papers 22
Julia A Knight
Co-authored papers 22
Stephen J Chanock
National Cancer Institute, National Institutes of Health
Co-authored papers 21
Release 1.2